MERCIALYS (MERY.PA) Fundamental Analysis & Valuation

EPA:MERYFR0010241638

Current stock price

12.46 EUR
+0.12 (+0.97%)
Last:

This MERY.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. MERY.PA Profitability Analysis

1.1 Basic Checks

  • In the past year MERY was profitable.
  • MERY had a positive operating cash flow in the past year.
  • In the past 5 years MERY has always been profitable.
  • Each year in the past 5 years MERY had a positive operating cash flow.
MERY.PA Yearly Net Income VS EBIT VS OCF VS FCFMERY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

1.2 Ratios

  • MERY has a Return On Assets of 1.40%. This is in the lower half of the industry: MERY underperforms 68.29% of its industry peers.
  • With a Return On Equity value of 5.71%, MERY perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 2.88%, MERY is doing worse than 60.98% of the companies in the same industry.
Industry RankSector Rank
ROA 1.4%
ROE 5.71%
ROIC 2.88%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MERY.PA Yearly ROA, ROE, ROICMERY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of MERY (18.81%) is worse than 65.85% of its industry peers.
  • In the last couple of years the Profit Margin of MERY has declined.
  • MERY has a Operating Margin of 43.62%. This is in the lower half of the industry: MERY underperforms 68.29% of its industry peers.
  • MERY's Operating Margin has been stable in the last couple of years.
  • MERY has a better Gross Margin (94.41%) than 90.24% of its industry peers.
  • In the last couple of years the Gross Margin of MERY has grown nicely.
Industry RankSector Rank
OM 43.62%
PM (TTM) 18.81%
GM 94.41%
OM growth 3Y1.49%
OM growth 5Y0.83%
PM growth 3Y-8.89%
PM growth 5Y-17.4%
GM growth 3Y-0.47%
GM growth 5Y2.37%
MERY.PA Yearly Profit, Operating, Gross MarginsMERY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

4

2. MERY.PA Health Analysis

2.1 Basic Checks

  • MERY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • MERY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MERY.PA Yearly Shares OutstandingMERY.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MERY.PA Yearly Total Debt VS Total AssetsMERY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • MERY has an Altman-Z score of 0.61. This is a bad value and indicates that MERY is not financially healthy and even has some risk of bankruptcy.
  • MERY has a Altman-Z score of 0.61. This is in the lower half of the industry: MERY underperforms 73.17% of its industry peers.
  • MERY has a debt to FCF ratio of 10.77. This is a negative value and a sign of low solvency as MERY would need 10.77 years to pay back of all of its debts.
  • MERY has a better Debt to FCF ratio (10.77) than 68.29% of its industry peers.
  • MERY has a Debt/Equity ratio of 2.21. This is a high value indicating a heavy dependency on external financing.
  • MERY has a worse Debt to Equity ratio (2.21) than 92.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.21
Debt/FCF 10.77
Altman-Z 0.61
ROIC/WACC0.39
WACC7.45%
MERY.PA Yearly LT Debt VS Equity VS FCFMERY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • MERY has a Current Ratio of 1.19. This is a normal value and indicates that MERY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of MERY (1.19) is better than 87.80% of its industry peers.
  • MERY has a Quick Ratio of 1.19. This is a normal value and indicates that MERY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of MERY (1.19) is better than 90.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
MERY.PA Yearly Current Assets VS Current LiabilitesMERY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. MERY.PA Growth Analysis

3.1 Past

  • MERY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.82%.
  • MERY shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.31% yearly.
  • MERY shows a small growth in Revenue. In the last year, the Revenue has grown by 0.59%.
  • The Revenue has been growing slightly by 0.58% on average over the past years.
EPS 1Y (TTM)-36.82%
EPS 3Y-7.55%
EPS 5Y-17.31%
EPS Q2Q%14.4%
Revenue 1Y (TTM)0.59%
Revenue growth 3Y1.39%
Revenue growth 5Y0.58%
Sales Q2Q%4.41%

3.2 Future

  • MERY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.84% yearly.
  • The Revenue is expected to grow by 2.20% on average over the next years.
EPS Next Y13.31%
EPS Next 2Y7.03%
EPS Next 3Y4.84%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2Y2.61%
Revenue Next 3Y2.2%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MERY.PA Yearly Revenue VS EstimatesMERY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
MERY.PA Yearly EPS VS EstimatesMERY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

4

4. MERY.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 34.61, MERY can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, MERY is valued a bit more expensive than the industry average as 73.17% of the companies are valued more cheaply.
  • The average S&P500 Price/Earnings ratio is at 26.77. MERY is valued slightly more expensive when compared to this.
  • A Price/Forward Earnings ratio of 9.67 indicates a reasonable valuation of MERY.
  • MERY's Price/Forward Earnings ratio is rather cheap when compared to the industry. MERY is cheaper than 85.37% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.75, MERY is valued rather cheaply.
Industry RankSector Rank
PE 34.61
Fwd PE 9.67
MERY.PA Price Earnings VS Forward Price EarningsMERY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MERY is valued a bit cheaper than the industry average as 68.29% of the companies are valued more expensively.
  • 82.93% of the companies in the same industry are more expensive than MERY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.45
EV/EBITDA 16.14
MERY.PA Per share dataMERY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MERY does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.6
PEG (5Y)N/A
EPS Next 2Y7.03%
EPS Next 3Y4.84%

5

5. MERY.PA Dividend Analysis

5.1 Amount

  • MERY has a Yearly Dividend Yield of 7.90%, which is a nice return.
  • Compared to an average industry Dividend Yield of 5.38, MERY pays a better dividend. On top of this MERY pays more dividend than 85.37% of the companies listed in the same industry.
  • MERY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 7.9%

5.2 History

  • The dividend of MERY decreases each year by -1.82%.
Dividend Growth(5Y)-1.82%
Div Incr Years4
Div Non Decr Years5
MERY.PA Yearly Dividends per shareMERY.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 275.18% of the earnings are spent on dividend by MERY. This is not a sustainable payout ratio.
DP275.18%
EPS Next 2Y7.03%
EPS Next 3Y4.84%
MERY.PA Yearly Income VS Free CF VS DividendMERY.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
MERY.PA Dividend Payout.MERY.PA Dividend Payout, showing the Payout Ratio.MERY.PA Dividend Payout.PayoutRetained Earnings

MERY.PA Fundamentals: All Metrics, Ratios and Statistics

MERCIALYS

EPA:MERY (4/30/2026, 7:00:00 PM)

12.46

+0.12 (+0.97%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Industry Strength62.16
Industry Growth75.33
Earnings (Last)02-17
Earnings (Next)07-28
Inst Owners47.88%
Inst Owner ChangeN/A
Ins Owners0.4%
Ins Owner ChangeN/A
Market Cap1.17B
Revenue(TTM)180.59M
Net Income(TTM)33.96M
Analysts75.71
Price Target13.45 (7.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.9%
Yearly Dividend0.99
Dividend Growth(5Y)-1.82%
DP275.18%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.94%
PT rev (3m)4.46%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.03%
EPS NY rev (3m)7.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.4%
Valuation
Industry RankSector Rank
PE 34.61
Fwd PE 9.67
P/S 6.48
P/FCF 7.45
P/OCF 7.45
P/B 1.97
P/tB 2.05
EV/EBITDA 16.14
EPS(TTM)0.36
EY2.89%
EPS(NY)1.29
Fwd EY10.34%
FCF(TTM)1.67
FCFY13.42%
OCF(TTM)1.67
OCFY13.42%
SpS1.92
BVpS6.34
TBVpS6.08
PEG (NY)2.6
PEG (5Y)N/A
Graham Number7.16513 (-42.49%)
Profitability
Industry RankSector Rank
ROA 1.4%
ROE 5.71%
ROCE 3.91%
ROIC 2.88%
ROICexc 3.67%
ROICexgc 3.73%
OM 43.62%
PM (TTM) 18.81%
GM 94.41%
FCFM 86.95%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.49%
OM growth 5Y0.83%
PM growth 3Y-8.89%
PM growth 5Y-17.4%
GM growth 3Y-0.47%
GM growth 5Y2.37%
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 2.21
Debt/FCF 10.77
Debt/EBITDA 8.77
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.37
Cash Conversion 104.51%
Profit Quality 462.33%
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 0.61
F-Score4
WACC7.45%
ROIC/WACC0.39
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)338.13%
Profit Quality(5y)316.21%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.82%
EPS 3Y-7.55%
EPS 5Y-17.31%
EPS Q2Q%14.4%
EPS Next Y13.31%
EPS Next 2Y7.03%
EPS Next 3Y4.84%
EPS Next 5YN/A
Revenue 1Y (TTM)0.59%
Revenue growth 3Y1.39%
Revenue growth 5Y0.58%
Sales Q2Q%4.41%
Revenue Next Year3.21%
Revenue Next 2Y2.61%
Revenue Next 3Y2.2%
Revenue Next 5YN/A
EBIT growth 1Y-22.88%
EBIT growth 3Y2.89%
EBIT growth 5Y1.41%
EBIT Next Year35.47%
EBIT Next 3Y11.64%
EBIT Next 5YN/A
FCF growth 1Y-2.79%
FCF growth 3Y1.51%
FCF growth 5Y3.09%
OCF growth 1Y-2.79%
OCF growth 3Y1.51%
OCF growth 5Y3.09%

MERCIALYS / MERY.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MERCIALYS?

ChartMill assigns a fundamental rating of 4 / 10 to MERY.PA.


What is the valuation status for MERY stock?

ChartMill assigns a valuation rating of 4 / 10 to MERCIALYS (MERY.PA). This can be considered as Fairly Valued.


What is the profitability of MERY stock?

MERCIALYS (MERY.PA) has a profitability rating of 4 / 10.


What is the financial health of MERCIALYS (MERY.PA) stock?

The financial health rating of MERCIALYS (MERY.PA) is 4 / 10.


Is the dividend of MERCIALYS sustainable?

The dividend rating of MERCIALYS (MERY.PA) is 5 / 10 and the dividend payout ratio is 275.18%.